Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL). // Gynecologic Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0090825826021633?dgcid=rss_sd_all
Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL). Gynecologic Oncology. https://www.sciencedirect.com/science/article/pii/S0090825826021633?dgcid=rss_sd_all
“Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL).” Gynecologic Oncology.
@article{article47473,
title = {Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL)},
journal = {Gynecologic Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0090825826021633?dgcid=rss_sd_all}
}